Extending the Time Window for Endovascular and Pharmacological Reperfusion (original) (raw)

• Puyal J, Ginet V, Clarke PG. Multiple interacting cell death mechanisms in the mediation of excitotoxicity and ischemic brain damage: a challenge for neuroprotection. Prog Neurobiol. 2013;105:24–48. doi:10.1016/j.pneurobio.2013.03.002.
  Article PubMed Google Scholar
• Schabitz WR, Fisher M. Perspectives on neuroprotective stroke therapy. Biochem Soc Trans. 2006;34:1271–6. doi:10.1042/BST0341271.
  Article PubMed Google Scholar
• Henninger N, Kumar R, Fisher M. Acute ischemic stroke therapy. Expert Rev Cardiovasc Ther. 2010;8:1389–98. doi:10.1586/erc.10.128.
  Article PubMed Google Scholar
• Savitz SI, Fisher M. Future of neuroprotection for acute stroke: in the aftermath of the SAINT trials. Ann Neurol. 2007;61:396–402. doi:10.1002/ana.21127.
  Article CAS PubMed Google Scholar
• Stroke therapy academic industry roundtable (STAIR). Recommendations for standards regarding preclinical neuroprotective and restorative drug development. Stroke. 1999;30(12):2752–8.
• Stroke therapy academic industry roundtable II (STAIR-II). Recommendations for clinical trial evaluation of acute stroke therapies. Stroke. 2001;32(7):1598–606.
• Fisher M, Feuerstein G, Howells DW, Hurn PD, Kent TA, Savitz SI, et al. Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke. 2009;40:2244–50. doi:10.1161/STROKEAHA.108.541128.
  Article PubMed PubMed Central Google Scholar
• Saver JL, Jovin TG, Smith WS, Albers GW, Baron JC, Boltze J, et al. Stroke treatment academic industry roundtable: research priorities in the assessment of neurothrombectomy devices. Stroke. 2013;44:3596–601. doi:10.1161/STROKEAHA.113.002769.
  Article CAS PubMed PubMed Central Google Scholar
• Sena E, van der Worp HB, Howells D, Macleod M. How can we improve the pre-clinical development of drugs for stroke? Trends Neurosci. 2007;30:433–9. doi:10.1016/j.tins.2007.06.009.
  Article CAS PubMed Google Scholar
• Llovera G, Hofmann K, Roth S, Salas-Perdomo A, Ferrer-Ferrer M, Perego C, et al. Results of a preclinical randomized controlled multicenter trial (pRCT): anti-CD49d treatment for acute brain ischemia. Sci Transl Med. 2015;7:299ra121. doi:10.1126/scitranslmed.aaa9853.
  Article PubMed Google Scholar
• The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581–7.
• Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;359:1317–29. doi:10.1056/NEJMoa0804656.
  Article CAS PubMed Google Scholar
• Emberson J, Lees KR, Lyden P, Blackwell L, Albers G, Bluhmki E, et al. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet. 2014;384:1929–35. doi:10.1016/S0140-6736(14)60584-5.
  Article CAS PubMed PubMed Central Google Scholar
• Albers GW, Goyal M, Jahan R, Bonafe A, Diener HC, Levy EI, et al. Relationships between imaging assessments and outcomes in Solitaire with the intention for thrombectomy as primary endovascular treatment for acute ischemic stroke. Stroke. 2015;46:2786–94. doi:10.1161/STROKEAHA.115.010710.
  Article CAS PubMed Google Scholar
• Parsons M, Spratt N, Bivard A, Campbell B, Chung K, Miteff F, et al. A randomized trial of tenecteplase versus alteplase for acute ischemic stroke. N Engl J Med. 2012;366:1099–107. doi:10.1056/NEJMoa1109842.
  Article CAS PubMed Google Scholar
• Berkhemer OA, Fransen PS, Beumer D, van den Berg LA, Lingsma HF, Yoo AJ, et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2015;372:11–20. doi:10.1056/NEJMoa1411587.
  Article PubMed Google Scholar
• Goyal M, Demchuk AM, Menon BK, Eesa M, Rempel JL, Thornton J, et al. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med. 2015;372:1019–30. doi:10.1056/NEJMoa1414905.
  Article CAS PubMed Google Scholar
• Saver JL, Goyal M, Bonafe A, Diener HC, Levy EI, Pereira VM, et al. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med. 2015. doi:10.1056/NEJMoa1415061.
  PubMed Central Google Scholar
• Campbell BC, Mitchell PJ, Kleinig TJ, Dewey HM, Churilov L, Yassi N, et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med. 2015;372:1009–18. doi:10.1056/NEJMoa1414792.
  Article CAS PubMed Google Scholar
• Jovin TG, Chamorro A, Cobo E, de Miquel MA, Molina CA, Rovira A, et al. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med. 2015;372:2296–306. doi:10.1056/NEJMoa1503780.
  Article CAS PubMed Google Scholar
• Broderick JP, Palesch YY, Demchuk AM, Yeatts SD, Khatri P, Hill MD, et al. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med. 2013;368:893–903. doi:10.1056/NEJMoa1214300.
  Article CAS PubMed PubMed Central Google Scholar
• Shen Q, Ren H, Cheng H, Fisher M, Duong TQ. Functional, perfusion and diffusion MRI of acute focal ischemic brain injury. J Cereb Blood Flow Metab. 2005;25:1265–79. doi:10.1038/sj.jcbfm.9600132.
  Article PubMed PubMed Central Google Scholar
• Fisher M. The ischemic penumbra: a new opportunity for neuroprotection. Cerebrovasc Dis. 2006;21 Suppl 2:64–70. doi:10.1159/000091705.
  Article PubMed Google Scholar
• Saver JL. Time is brain--quantified. Stroke. 2006;37:263–6. doi:10.1161/01.STR.0000196957.55928.ab.
  Article PubMed Google Scholar
• Sandercock P, Wardlaw JM, Lindley RI, Dennis M, Cohen G, Murray G, et al. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial. Lancet. 2012;379:2352–63. doi:10.1016/S0140-6736(12)60768-5.
  Article PubMed Google Scholar
• Kidwell CS, Jahan R, Gornbein J, Alger JR, Nenov V, Ajani Z, et al. A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med. 2013;368:914–23. doi:10.1056/NEJMoa1212793.
  Article CAS PubMed PubMed Central Google Scholar
• Nagakane Y, Christensen S, Brekenfeld C, Ma H, Churilov L, Parsons MW, et al. EPITHET: positive result after reanalysis using baseline diffusion-weighted imaging/perfusion-weighted imaging co-registration. Stroke. 2011;42:59–64. doi:10.1161/STROKEAHA.110.580464.
  Article PubMed Google Scholar
• Wheeler HM, Mlynash M, Inoue M, Tipirneni A, Liggins J, Zaharchuk G, et al. Early diffusion-weighted imaging and perfusion-weighted imaging lesion volumes forecast final infarct size in DEFUSE 2. Stroke. 2013;44:681–5. doi:10.1161/STROKEAHA.111.000135.
  Article PubMed PubMed Central Google Scholar
• Lansberg MG, Cereda CW, Mlynash M, Mishra NK, Inoue M, Kemp S, et al. Response to endovascular reperfusion is not time-dependent in patients with salvageable tissue. Neurology. 2015;85:708–14. doi:10.1212/WNL.0000000000001853.
  Article PubMed Google Scholar
• Wintermark M, Flanders AE, Velthuis B, Meuli R, van Leeuwen M, Goldsher D, et al. Perfusion-CT assessment of infarct core and penumbra: receiver operating characteristic curve analysis in 130 patients suspected of acute hemispheric stroke. Stroke. 2006;37:979–85. doi:10.1161/01.STR.0000209238.61459.39.
  Article PubMed Google Scholar
• Lin L, Bivard A, Levi CR, Parsons MW. Comparison of computed tomographic and magnetic resonance perfusion measurements in acute ischemic stroke: back-to-back quantitative analysis. Stroke. 2014;45:1727–32. doi:10.1161/STROKEAHA.114.005419.
  Article PubMed Google Scholar
• Liebeskind DS, Jahan R, Nogueira RG, Jovin TG, Lutsep HL, Saver JL. Serial Alberta Stroke Program early CT score from baseline to 24 hours in Solitaire Flow Restoration with the Intention for Thrombectomy study: a novel surrogate end point for revascularization in acute stroke. Stroke. 2014;45:723–7. doi:10.1161/STROKEAHA.113.003914.
  Article PubMed PubMed Central Google Scholar
• Bratane BT, Cui H, Cook DJ, Bouley J, Tymianski M, Fisher M. Neuroprotection by freezing ischemic penumbra evolution without cerebral blood flow augmentation with a postsynaptic density-95 protein inhibitor. Stroke. 2011;42:3265–70. doi:10.1161/STROKEAHA.111.618801.
  Article CAS PubMed Google Scholar
• Henninger N, Bratane BT, Bastan B, Bouley J, Fisher M. Normobaric hyperoxia and delayed tPA treatment in a rat embolic stroke model. J Cereb Blood Flow Metab. 2009;29:119–29. doi:10.1038/jcbfm.2008.104.
  Article CAS PubMed Google Scholar
• Badhiwala JH, Nassiri F, Alhazzani W, Selim MH, Farrokhyar F, Spears J, et al. Endovascular thrombectomy for acute ischemic stroke: a meta-analysis. JAMA. 2015;314:1832–43. doi:10.1001/jama.2015.13767.
  Article CAS PubMed Google Scholar
• Meyers PM, Schumacher HC, Connolly Jr ES, Heyer EJ, Gray WA, Higashida RT. Current status of endovascular stroke treatment. Circulation. 2011;123:2591–601. doi:10.1161/CIRCULATIONAHA.110.971564.
  Article PubMed PubMed Central Google Scholar
• Cloft HJ, Rabinstein A, Lanzino G, Kallmes DF. Intra-arterial stroke therapy: an assessment of demand and available work force. AJNR Am J Neuroradiol. 2009;30:453–8. doi:10.3174/ajnr.A1462.
  Article CAS PubMed Google Scholar
• Wardlaw JM, Dennis MS. Thrombectomy for acute ischemic stroke. JAMA. 2015;314:1803–5. doi:10.1001/jama.2015.14674.
  Article CAS PubMed Google Scholar
• Kleindorfer D, Lindsell CJ, Brass L, Koroshetz W, Broderick JP. National US estimates of recombinant tissue plasminogen activator use: ICD-9 codes substantially underestimate. Stroke. 2008;39:924–8. doi:10.1161/STROKEAHA.107.490375.
  Article PubMed Google Scholar
• Asplund K, Glader EL, Norrving B, Eriksson M. Effects of extending the time window of thrombolysis to 4.5 hours: observations in the Swedish stroke register (riks-stroke). Stroke. 2011;42:2492–7. doi:10.1161/STROKEAHA.111.618587.
  Article PubMed Google Scholar
• Adeoye O, Hornung R, Khatri P, Kleindorfer D. Recombinant tissue-type plasminogen activator use for ischemic stroke in the United States: a doubling of treatment rates over the course of 5 years. Stroke. 2011;42:1952–5. doi:10.1161/STROKEAHA.110.612358.
  Article CAS PubMed PubMed Central Google Scholar
• O’Collins VE, Macleod MR, Donnan GA, Horky LL, van der Worp BH, Howells DW. 1,026 experimental treatments in acute stroke. Ann Neurol. 2006;59:467–77. doi:10.1002/ana.20741.
  Article PubMed Google Scholar
• Minnerup J, Sutherland BA, Buchan AM, Kleinschnitz C. Neuroprotection for stroke: current status and future perspectives. Int J Mol Sci. 2012;13:11753–72. doi:10.3390/ijms130911753.
  Article CAS PubMed PubMed Central Google Scholar
• Philip M, Benatar M, Fisher M, Savitz SI. Methodological quality of animal studies of neuroprotective agents currently in phase II/III acute ischemic stroke trials. Stroke. 2009;40:577–81. doi:10.1161/STROKEAHA.108.524330.
  Article CAS PubMed Google Scholar
• Tymianski M. Can molecular and cellular neuroprotection be translated into therapies for patients?: yes, but not the way we tried it before. Stroke. 2010;41:S87–90. doi:10.1161/STROKEAHA.110.595496.
  Article PubMed Google Scholar
• Mehra M, Henninger N, Hirsch JA, Chueh J, Wakhloo AK, Gounis MJ. Preclinical acute ischemic stroke modeling. J Neurointerv Surg. 2012;4:307–13. doi:10.1136/neurintsurg-2011-010101.
  Article PubMed Google Scholar
• Henninger N, Sicard KM, Schmidt KF, Bardutzky J, Fisher M. Comparison of ischemic lesion evolution in embolic versus mechanical middle cerebral artery occlusion in Sprague Dawley rats using diffusion and perfusion imaging. Stroke. 2006;37:1283–7. doi:10.1161/01.STR.0000217223.72193.98.
  Article PubMed Google Scholar
• Manning NW, Campbell BC, Oxley TJ, Chapot R. Acute ischemic stroke: time, penumbra, and reperfusion. Stroke. 2014;45:640–4. doi:10.1161/STROKEAHA.113.003798.
  Article PubMed Google Scholar
• Marosfoi MG, Korin N, Gounis MJ, Uzun O, Vedantham S, Langan ET, et al. Shear-activated nanoparticle aggregates combined with temporary endovascular bypass to treat large vessel occlusion. Stroke. 2015. doi:10.1161/STROKEAHA.115.011063.
  Google Scholar
• Henninger N, Bouley J, Nelligan JM, Sicard KM, Fisher M. Normobaric hyperoxia delays perfusion/diffusion mismatch evolution, reduces infarct volume, and differentially affects neuronal cell death pathways after suture middle cerebral artery occlusion in rats. J Cereb Blood Flow Metab. 2007;27:1632–42. doi:10.1038/sj.jcbfm.9600463.
  Article PubMed Google Scholar
• Kim HY, Singhal AB, Lo EH. Normobaric hyperoxia extends the reperfusion window in focal cerebral ischemia. Ann Neurol. 2005;57:571–5. doi:10.1002/ana.20430.
  Article PubMed Google Scholar
• Ip HL, Liebeskind DS. The future of ischemic stroke: flow from prehospital neuroprotection to definitive reperfusion. Interv Neurol. 2014;2:105–17. doi:10.1159/000357164.
  Article PubMed PubMed Central Google Scholar
• Jung JE, Kim GS, Chen H, Maier CM, Narasimhan P, Song YS, et al. Reperfusion and neurovascular dysfunction in stroke: from basic mechanisms to potential strategies for neuroprotection. Mol Neurobiol. 2010;41:172–9. doi:10.1007/s12035-010-8102-z.
  Article CAS PubMed PubMed Central Google Scholar
• Bardutzky J, Meng X, Bouley J, Duong TQ, Ratan R, Fisher M. Effects of intravenous dimethyl sulfoxide on ischemia evolution in a rat permanent occlusion model. J Cereb Blood Flow Metab. 2005;25:968–77. doi:10.1038/sj.jcbfm.9600095.
  Article CAS PubMed PubMed Central Google Scholar
• Henninger N, Fisher M. Stimulating circle of Willis nerve fibers preserves the diffusion-perfusion mismatch in experimental stroke. Stroke. 2007;38:2779–86. doi:10.1161/STROKEAHA.107.485581.
  Article PubMed Google Scholar
• Bratane BT, Bouley J, Schneider A, Bastan B, Henninger N, Fisher M. Granulocyte-colony stimulating factor delays PWI/DWI mismatch evolution and reduces final infarct volume in permanent-suture and embolic focal cerebral ischemia models in the rat. Stroke. 2009;40:3102–6. doi:10.1161/STROKEAHA.109.553958.
  Article CAS PubMed Google Scholar
• Saver JL, Starkman S, Eckstein M, Stratton SJ, Pratt FD, Hamilton S, et al. Prehospital use of magnesium sulfate as neuroprotection in acute stroke. N Engl J Med. 2015;372:528–36. doi:10.1056/NEJMoa1408827.
  Article PubMed PubMed Central Google Scholar
• Ebinger M, Winter B, Wendt M, Weber JE, Waldschmidt C, Rozanski M, et al. Effect of the use of ambulance-based thrombolysis on time to thrombolysis in acute ischemic stroke: a randomized clinical trial. JAMA. 2014;311:1622–31. doi:10.1001/jama.2014.2850.
  Article CAS PubMed Google Scholar
• Audebert HJ, Saver JL, Starkman S, Lees KR, Endres M. Prehospital stroke care: new prospects for treatment and clinical research. Neurology. 2013;81:501–8. doi:10.1212/WNL.0b013e31829e0fdd.
  Article CAS PubMed PubMed Central Google Scholar
• Korin N, Kanapathipillai M, Matthews BD, Crescente M, Brill A, Mammoto T, et al. Shear-activated nanotherapeutics for drug targeting to obstructed blood vessels. Science. 2012;337:738–42. doi:10.1126/science.1217815.
  Article CAS PubMed Google Scholar
• van der Worp HB, Macleod MR, Bath PM, Demotes J, Durand-Zaleski I, Gebhardt B, et al. EuroHYP-1: European multicenter, randomized, phase III clinical trial of therapeutic hypothermia plus best medical treatment vs. best medical treatment alone for acute ischemic stroke. Int J Stroke. 2014;9:642–5. doi:10.1111/ijs.12294.
  Article PubMed Google Scholar
• Horn CM, Sun CH, Nogueira RG, Patel VN, Krishnan A, Glenn BA, et al. Endovascular Reperfusion and Cooling in Cerebral Acute Ischemia (ReCCLAIM I). J Neurointerv Surg. 2014;6:91–5. doi:10.1136/neurintsurg-2013-010656.
  Article PubMed Google Scholar
• van der Worp HB, Sena ES, Donnan GA, Howells DW, Macleod MR. Hypothermia in animal models of acute ischaemic stroke: a systematic review and meta-analysis. Brain. 2007;130:3063–74. doi:10.1093/brain/awm083.
  Article PubMed Google Scholar
• Donnino MW, Andersen LW, Berg KM, Reynolds JC, Nolan JP, Morley PT, et al. Temperature management after cardiac arrest: an advisory statement by the Advanced Life Support Task Force of the International Liaison Committee on Resuscitation and the American Heart Association Emergency Cardiovascular Care Committee and the Council on Cardiopulmonary, Critical Care. Perioper Resuscitation Circ. 2015. doi:10.1161/CIR.0000000000000313.
  Google Scholar
• Kuliha M, Roubec M, Jonszta T, Krajca J, Czerny D, Krajina A, et al. Safety and efficacy of endovascular sonolysis using the EkoSonic endovascular system in patients with acute stroke. AJNR Am J Neuroradiol. 2013;34:1401–6. doi:10.3174/ajnr.A3416.
  Article CAS PubMed Google Scholar
• Schellinger PD, Alexandrov AV, Barreto AD, Demchuk AM, Tsivgoulis G, Kohrmann M, et al. Combined lysis of thrombus with ultrasound and systemic tissue plasminogen activator for emergent revascularization in acute ischemic stroke (CLOTBUST-ER): design and methodology of a multinational phase 3 trial. Int J Stroke. 2015;10:1141–8. doi:10.1111/ijs.12536.
  Article PubMed Google Scholar
• Fisher M, Saver JL. Future directions of acute ischaemic stroke therapy. Lancet Neurol. 2015;14:758–67. doi:10.1016/S1474-4422(15)00054-X.
  Article PubMed Google Scholar
• dela Pena IC, Yoo A, Tajiri N, Acosta SA, Ji X, Kaneko Y, et al. Granulocyte colony-stimulating factor attenuates delayed tPA-induced hemorrhagic transformation in ischemic stroke rats by enhancing angiogenesis and vasculogenesis. J Cereb Blood Flow Metab. 2015;35:338–46. doi:10.1038/jcbfm.2014.208.
  Article Google Scholar
• Iadecola C, Anrather J. The immunology of stroke: from mechanisms to translation. Nat Med. 2011;17:796–808. doi:10.1038/nm.2399.
  Article CAS PubMed PubMed Central Google Scholar
• Sanderson TH, Reynolds CA, Kumar R, Przyklenk K, Huttemann M. Molecular mechanisms of ischemia-reperfusion injury in brain: pivotal role of the mitochondrial membrane potential in reactive oxygen species generation. Mol Neurobiol. 2013;47:9–23. doi:10.1007/s12035-012-8344-z.
  Article CAS PubMed Google Scholar
• Warach S, Latour LL. Evidence of reperfusion injury, exacerbated by thrombolytic therapy, in human focal brain ischemia using a novel imaging marker of early blood-brain barrier disruption. Stroke. 2004;35:2659–61. doi:10.1161/01.STR.0000144051.32131.09.
  Article PubMed Google Scholar
• Leigh R, Jen SS, Hillis AE, Krakauer JW, Barker PB. Pretreatment blood-brain barrier damage and post-treatment intracranial hemorrhage in patients receiving intravenous tissue-type plasminogen activator. Stroke. 2014;45:2030–5. doi:10.1161/STROKEAHA.114.005249.
  Article CAS PubMed PubMed Central Google Scholar
• Berger C, Fiorelli M, Steiner T, Schabitz WR, Bozzao L, Bluhmki E, et al. Hemorrhagic transformation of ischemic brain tissue: asymptomatic or symptomatic? Stroke. 2001;32:1330–5.
  Article CAS PubMed Google Scholar
• Kent DM, Hinchey J, Price LL, Levine SR, Selker HP. In acute ischemic stroke, are asymptomatic intracranial hemorrhages clinically innocuous? Stroke. 2004;35:1141–6. doi:10.1161/01.STR.0000125712.02090.6e.
  Article PubMed Google Scholar
• Lei C, Wu B, Liu M, Chen Y. Asymptomatic hemorrhagic transformation after acute ischemic stroke: is it clinically innocuous? J Stroke Cerebrovasc Dis. 2014;23:2767–72. doi:10.1016/j.jstrokecerebrovasdis.2014.06.024.
  Article PubMed Google Scholar
• Park JH, Ko Y, Kim WJ, Jang MS, Yang MH, Han MK, et al. Is asymptomatic hemorrhagic transformation really innocuous? Neurology. 2012;78:421–6. doi:10.1212/WNL.0b013e318245d22c.
  Article CAS PubMed Google Scholar
• Dzialowski I, Pexman JH, Barber PA, Demchuk AM, Buchan AM, Hill MD. Asymptomatic hemorrhage after thrombolysis may not be benign: prognosis by hemorrhage type in the Canadian Alteplase for Stroke Effectiveness Study registry. Stroke. 2007;38:75–9. doi:10.1161/01.STR.0000251644.76546.62.
  Article PubMed Google Scholar
• Zhu Z, Fu Y, Tian D, Sun N, Han W, Chang G, et al. Combination of the immune modulator fingolimod with alteplase in acute ischemic stroke: a pilot trial. Circulation. 2015;132:1104–12. doi:10.1161/CIRCULATIONAHA.115.016371.
  Article CAS PubMed Google Scholar
• Schwamm LH, Holloway RG, Amarenco P, Audebert HJ, Bakas T, Chumbler NR, et al. A review of the evidence for the use of telemedicine within stroke systems of care: a scientific statement from the American Heart Association/American Stroke Association. Stroke. 2009;40:2616–34. doi:10.1161/STROKEAHA.109.192360.
  Article PubMed Google Scholar